SAMRAT PHARMACHEM LTD.

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
INCOME :
Sales Turnover	125.36	105.35	78.58	68.3	51.46
Other Income	0.46	0.25	0.16	0.21	0.35
Stock Adjustments	0.91	0.51	0.28	0.15	-2.05
Total Income	126.73	106.11	79.02	68.66	49.76
EXPENDITURE :
Raw Materials	103.53	82.43	62.95	56.46	40.66
Excise Duty	14.22	12.41	5.84	5.1	4.07
Power and Fuel Cost	0.73	0.82	0.63	0.74	0.75
Other Manufacturing Expenses	1.52	1.03	1.69	1.23	0.83
Employee Cost	0.94	0.85	0.76	0.66	0.62
Selling and Administration Expenses	2.09	2.31	3.11	3.03	1.28
Miscellaneous Expenses	0.05	0.05	0.19	0.03	0.05
Less: Preoperative Expenditure Capitalised	0	0	0	0	0
Profit before Interest, Depreciation and Tax	3.64	6.19	3.84	1.4	1.51
Interest and Financial Charges	1.06	0.86	0.63	0.51	0.59
Profit before Depreciation and Tax	2.58	5.33	3.21	0.89	0.92
Depreciation	0.42	0.41	0.43	0.44	0.44
Profit Before Tax	2.16	4.92	2.77	0.45	0.48
Tax	0.62	1.7	1.02	0.15	0.16
Profit After Tax	1.54	3.22	1.75	0.3	0.32
Adjustment below Net Profit	0	0	0	0	0
P and L Balance brought forward	15.44	12.22	10.47	10.37	10.05
Appropriations	0	0	0	0	0
P and L Bal. carried down	16.98	15.44	12.22	10.67	10.37
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Corporate Dividend Tax	0	0	0	0	0
Equity Dividend (%)	0	0	0	0	0
Earning Per Share (Rs.)	4.97	10.41	5.68	0.98	1.02
Book Value	64.95	59.98	49.57	44.52	43.55
Extraordinary Items	0	0	0.01	0.01	-0.01

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

INCOME :

Sales Turnover

125.36

105.35

78.58

68.3

51.46

Other Income

0.46

0.25

0.16

0.21

0.35

Stock Adjustments

0.91

0.51

0.28

0.15

-2.05

Total Income

126.73

106.11

79.02

68.66

49.76

EXPENDITURE :

Raw Materials

103.53

82.43

62.95

56.46

40.66

Excise Duty

14.22

12.41

5.84

5.1

4.07

Power and Fuel Cost

0.73

0.82

0.63

0.74

0.75

Other Manufacturing Expenses

1.52

1.03

1.69

1.23

0.83

Employee Cost

0.94

0.85

0.76

0.66

0.62

Selling and Administration Expenses

2.09

2.31

3.11

3.03

1.28

Miscellaneous Expenses

0.05

0.19

0.03

0.05

Less: Preoperative Expenditure Capitalised

Profit before Interest, Depreciation and Tax

3.64

6.19

3.84

1.4

1.51

Interest and Financial Charges

1.06

0.86

0.63

0.51

0.59

Profit before Depreciation and Tax

2.58

5.33

3.21

0.89

0.92

Depreciation

0.42

0.41

0.43

0.44

Profit Before Tax

2.16

4.92

2.77

0.45

0.48

Tax

0.62

1.7

1.02

0.15

0.16

Profit After Tax

1.54

3.22

1.75

0.3

0.32

Adjustment below Net Profit

P and L Balance brought forward

15.44

12.22

10.47

10.37

10.05

Appropriations

P and L Bal. carried down

16.98

15.44

12.22

10.67

10.37

Equity Dividend

Preference Dividend

Corporate Dividend Tax

Equity Dividend (%)

Earning Per Share (Rs.)

4.97

10.41

5.68

0.98

1.02

Book Value

64.95

59.98

49.57

44.52

43.55

Extraordinary Items

0.01

-0.01

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
SOURCES OF FUNDS :
Share Capital	3.09	3.09	3.09	3.09	3.09
Reserves and Surplus	16.98	15.44	12.22	10.67	10.37
Total Shareholders Funds	20.07	18.53	15.31	13.76	13.46
Secured Loans	6.53	9.39	5.79	5.56	3.26
Unsecured Loans	0.2	0.2	1.36	0	0
Total Debt	6.73	9.59	7.15	5.56	3.26
Total Liabilities	26.8	28.12	22.46	19.32	16.72
APPLICATION OF FUNDS :
Gross Block	10.92	10.62	10.24	9.81	9.4
Less: Accum. Depreciation	4.05	3.63	3.22	2.53	2.17
Net Block	6.87	6.99	7.02	7.28	7.23
Capital Work in Progress	0	0	0.2	0	0
Investments	0	0	0	2	0
Current Assets, Loans and Advances
Inventories	7.93	6.85	7.02	5.68	4.47
Sundry Debtors	21.05	21.89	11.84	16.1	9.62
Cash and Bank Balance	2.25	3.98	2.44	3.5	3.94
Loans and Advances	2.31	1.29	7.77	1.69	1.04
Less: Current Liab. and Prov.
Current Liabilities	13.23	11.46	13.22	16.84	9.58
Provisions	0.37	1.41	0.6	0.1	0
Net Current Assets	19.94	21.14	15.25	10.03	9.49
Miscellaneous Expenses not w/o	0	0	0	0	0
Total Assets	26.81	28.13	22.47	19.31	16.72
Contingent Liabilities	0.43	0.36	0.36	0.37	3.49

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

SOURCES OF FUNDS :

Share Capital

3.09

Reserves and Surplus

16.98

15.44

12.22

10.67

10.37

Total Shareholders Funds

20.07

18.53

15.31

13.76

13.46

Secured Loans

6.53

9.39

5.79

5.56

3.26

Unsecured Loans

0.2

1.36

Total Debt

6.73

9.59

7.15

5.56

3.26

Total Liabilities

26.8

28.12

22.46

19.32

16.72

APPLICATION OF FUNDS :

Gross Block

10.92

10.62

10.24

9.81

9.4

Less: Accum. Depreciation

4.05

3.63

3.22

2.53

2.17

Net Block

6.87

6.99

7.02

7.28

7.23

Capital Work in Progress

0.2

Investments

Current Assets, Loans and Advances

Inventories

7.93

6.85

7.02

5.68

4.47

Sundry Debtors

21.05

21.89

11.84

16.1

9.62

Cash and Bank Balance

2.25

3.98

2.44

3.5

3.94

Loans and Advances

2.31

1.29

7.77

1.69

1.04

Less: Current Liab. and Prov.

Current Liabilities

13.23

11.46

13.22

16.84

9.58

Provisions

0.37

1.41

0.6

0.1

Net Current Assets

19.94

21.14

15.25

10.03

9.49

Miscellaneous Expenses not w/o

Total Assets

26.81

28.13

22.47

19.31

16.72

Contingent Liabilities

0.43

0.36

0.37

3.49

SAMRAT PHARMACHEM LTD.

Enjoy Lifetime Free Delivery Trade